Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile.

Alfredo Palacios Federico Rodriguez CairoliDario BalanCarlos Balmaceda Federico Augustovski Andrés Pichón-Riviere Ariel Esteban Bardach

Published in: Expert review of pharmacoeconomics & outcomes research (2023)

Incorporating the FSL for T1DM patients was associated with a marginal incremental cost for the public sector third-party payer and cost savings in Chile's private healthcare sector.

Keyphrases

healthcare
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
type diabetes
emergency department
adipose tissue
glycemic control
patient reported outcomes
insulin resistance
health information
electronic health record
affordable care act